Related Experiment Video
Updated: Jun 3, 2026

Analysis of the c-KIT Ligand Promoter Using Chromatin Immunoprecipitation
Published on: June 27, 2017
Sp1 is a transcription repressor to stanniocalcin-1 expression in TSA-treated human colon cancer cells, HT29
Alice Y S Law1, B H Y Yeung, L Y Ching
1Department of Biology, Hong Kong Baptist University, Kowloon Tong, Hong Kong.
Abstract:
Our previous study demonstrated that, stanniocalcin-1 (STC1) was a target of histone deacetylase (HDAC) inhibitors and was involved in trichostatin A (TSA) induced apoptosis in the human colon cancer cells, HT29. In this study, we reported that the transcriptional factor, specificity protein 1 (Sp1) in association with retinoblastoma (Rb) repressed STC1 gene transcription in TSA-treated HT29 cells. Our data demonstrated that, a co-treatment of the cells with TSA and Sp1 inhibitor, mithramycin A (MTM) led to a marked synergistic induction of STC1 transcript levels, STC1 promoter (1 kb)-driven luciferase activity and an increase of apoptotic cell population. The knockdown of Sp1 gene expression in TSA treated cells, revealed the repressor role of Sp1 in STC1 transcription. Using a protein phosphatase inhibitor okadaic acid (OKA), an increase of Sp1 hyperphosphorylation and so a reduction of its transcriptional activity, led to a significant induction of STC1 gene expression. Chromatin immunoprecipitation (ChIP) assay revealed that Sp1 binding on STC1 proximal promoter in TSA treated cells. The binding of Sp1 to STC1 promoter was abolished by the co-treatment of MTM or OKA in TSA-treated cells. Re-ChIP assay illustrated that Sp1-mediated inhibition of STC1 transcription was associated with the recruitment of another repressor molecule, Rb. Collectively our findings identify STC1 is a downstream target of Sp1.
Insights
Specificity protein 1 (Sp1) and retinoblastoma (Rb) repress stanniocalcin-1 (STC1) gene transcription in colon cancer cells. Inhibiting Sp1 or promoting Sp1 hyperphosphorylation synergistically increases STC1 levels and apoptosis.
Area of Science:
- Molecular Biology
- Cancer Research
- Gene Regulation
Background:
- Stanniocalcin-1 (STC1) is implicated in apoptosis in HT29 colon cancer cells following histone deacetylase (HDAC) inhibitor treatment.
- The precise mechanisms regulating STC1 expression in response to HDAC inhibitors require further elucidation.
Purpose of the Study:
- To investigate the role of specificity protein 1 (Sp1) and retinoblastoma (Rb) in regulating STC1 gene transcription in trichostatin A (TSA)-treated HT29 cells.
- To explore the therapeutic potential of targeting Sp1 in combination with HDAC inhibitors for colon cancer treatment.
Main Methods:
- Cell culture of HT29 human colon cancer cells.
- Treatment with TSA, Sp1 inhibitor mithramycin A (MTM), and protein phosphatase inhibitor okadaic acid (OKA).
- Gene expression analysis (STC1 transcript levels, luciferase activity), apoptosis assays, Sp1 knockdown, chromatin immunoprecipitation (ChIP), and re-ChIP assays.
Main Results:
- Sp1, in association with Rb, represses STC1 gene transcription in TSA-treated HT29 cells.
- Co-treatment with TSA and MTM synergistically enhances STC1 expression and apoptosis.
- Sp1 hyperphosphorylation, induced by OKA, reduces its transcriptional activity, leading to increased STC1 expression.
- ChIP and re-ChIP assays confirm Sp1 binding to the STC1 promoter and recruitment of Rb.
Conclusions:
- STC1 is identified as a downstream target gene regulated by Sp1.
- Sp1 acts as a transcriptional repressor of STC1, with its activity modulated by phosphorylation and Rb association.
- Targeting the Sp1/Rb/STC1 pathway presents a potential therapeutic strategy for colon cancer.
Related Concept Videos
The JAK-STAT Signaling Pathway
TGF - β Signaling Pathway
Co-activators and Co-repressors
Chromatin Modification in iPS Cells
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
Abnormal Proliferation
Cell Specific Gene Expression

